Connect Biopharma Holdings Ltd
NASDAQ:CNTB

Watchlist Manager
Connect Biopharma Holdings Ltd Logo
Connect Biopharma Holdings Ltd
NASDAQ:CNTB
Watchlist
Price: 2.82 USD 4.44%
Market Cap: 157.6m USD

Intrinsic Value

The intrinsic value of one CNTB stock under the Base Case scenario is 2.96 USD. Compared to the current market price of 2.82 USD, Connect Biopharma Holdings Ltd is Undervalued by 5%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CNTB Intrinsic Value
2.96 USD
Undervaluation 5%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Connect Biopharma Holdings Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about CNTB?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CNTB valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Connect Biopharma Holdings Ltd.

Explain Valuation
Compare CNTB to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CNTB?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Connect Biopharma Holdings Ltd

Balance Sheet Decomposition
Connect Biopharma Holdings Ltd

Current Assets 62.6m
Cash & Short-Term Investments 54.8m
Receivables 174k
Other Current Assets 7.6m
Non-Current Assets 4.8m
PP&E 4.7m
Intangibles 47k
Other Non-Current Assets 45k
Current Liabilities 11.4m
Accounts Payable 2m
Accrued Liabilities 9.3m
Other Current Liabilities 165k
Non-Current Liabilities 563k
Other Non-Current Liabilities 563k
Efficiency

Free Cash Flow Analysis
Connect Biopharma Holdings Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Connect Biopharma Holdings Ltd

Revenue
26.1m CNY
Operating Expenses
-79.7m CNY
Operating Income
-53.6m CNY
Other Expenses
7.8m CNY
Net Income
-45.7m CNY
Fundamental Scores

CNTB Profitability Score
Profitability Due Diligence

Connect Biopharma Holdings Ltd's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low Gross Margin
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
18/100
Profitability
Score

Connect Biopharma Holdings Ltd's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

CNTB Solvency Score
Solvency Due Diligence

Connect Biopharma Holdings Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
61/100
Solvency
Score

Connect Biopharma Holdings Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CNTB Price Targets Summary
Connect Biopharma Holdings Ltd

Wall Street analysts forecast CNTB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CNTB is 8.06 USD with a low forecast of 6.06 USD and a high forecast of 10.5 USD.

Lowest
Price Target
6.06 USD
115% Upside
Average
Price Target
8.06 USD
186% Upside
Highest
Price Target
10.5 USD
272% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Connect Biopharma Holdings Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for CNTB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one CNTB stock?

The intrinsic value of one CNTB stock under the Base Case scenario is 2.96 USD.

Is CNTB stock undervalued or overvalued?

Compared to the current market price of 2.82 USD, Connect Biopharma Holdings Ltd is Undervalued by 5%.

Back to Top